REHOVOT, Israel--(BUSINESS WIRE)--Pi-Cardia Ltd., a global leader in the development of leaflet modification solutions for treating heart valves, announced today that the United States Food and Drug ...
Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCut™ - the world's first ...
Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- For people undergoing valve-in-valve transcatheter ...
First Dedicated Leaflet Splitting Device To Facilitate Valve-in-Valve Procedures REHOVOT, ISRAEL / ACCESSWIRE / December 19, 2022 / Pi-Cardia Ltd., a global leader in the development of non-implant, ...
The Pi-Cardia Ltd. Shortcut — the catheter-based, leaflet modification solution for treating heart valves — received U.S. FDA clearance. The device was granted breakthrough device designation from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results